Find and Pitch Jounalists, Get Your Story Covered

Tags: hardware robotics startups funding industrial robotics

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	As financial headwinds pick up, pharmas are aiming to squeeze more ROI from their R&D - 17 days ago Pharma’s forecast for 2025: Sowing seeds of a rebound - 22 days ago PharmaVoice’s Crystal Ball: The industry’s AI future - about 2 months ago 3 closely watched drugs that failed in the clinic - 2 months ago Pharma takes aim at a wily foe — the Epstein-Barr virus - 4 months ago 2024 PharmaVoice 100s: Trailblazers - 4 months ago What 3 layoff stories reveal about pharma’s troubles - 6 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 9 months ago Where competition is heating up in pharma - 9 months ago The biggest questions hanging over pharma in 2024 - about 1 year ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - about 1 year ago PharmaVoice 100s: Entrepreneurs - over 1 year ago PharmaVoice 100s: Clinical trial gurus - over 1 year ago
2	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Up and down the ladder: The latest comings and goings - about 1 month ago STAT+: Up and down the ladder: The latest comings and goings - 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 5 months ago STAT+: Up and down the ladder: The latest comings and goings - 6 months ago STAT+: Up and down the ladder: The latest comings and goings - 6 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: U.K. trade group scolds Novo, Novartis, Pfizer, and Otsuka for violating industry codes - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 10 months ago STAT+: Up and down the ladder: The latest comings and goings - 11 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 11 months ago STAT+: Up and down the ladder: The latest comings and goings - 11 months ago STAT+: Up and down the ladder: The latest comings and goings - 11 months ago STAT+: Up and down the ladder: The latest comings and goings - 11 months ago STAT+: Up and down the ladder: The latest comings and goings - 11 months ago STAT+: Up and down the ladder: The latest comings and goings - 12 months ago STAT+: Up and down the ladder: The latest comings and goings - 12 months ago STAT+: Up and down the ladder: The latest comings and goings - 12 months ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - over 1 year ago STAT+: Up and down the ladder: The latest comings and goings - over 1 year ago STAT+: Up and Down the Ladder: The latest comings and goings - over 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - over 1 year ago STAT+: Up and down the ladder: The latest comings and goings - over 1 year ago STAT+: Up and down the ladder: The latest comings and goings - over 1 year ago STAT+: Up and down the ladder: The latest comings and goings - over 1 year ago
3	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	From Mr. Mucus to the Super Bowl, pharma tries offbeat marketing strategies - 3 months ago M&A is ready to explode, and that’s good news for pharma layoffs - 6 months ago As the GLP-1 market booms, other healthcare companies are cashing in - 8 months ago Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work? - 9 months ago
4	Pharmacy Times Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Unmasking Health Care Fraud: RICO Is Increasingly Being Used in the Pharmaceutical Industry - 4 months ago
5	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Big Pharma spends billions more on executives and stockholders than on R&D - about 1 year ago
6	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Pharmacists Are Vital to Heart Health - about 1 year ago
7	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	2024 - about 1 year ago
8	Nicholas Florko STAT News Reports on US health business. Washington, DC healthcarepolicy	STAT+: Medical marijuana companies are using pharma’s sales tactics with little of the same scrutiny - about 1 year ago
9	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing	What are pharma’s next blockbusters? - about 1 year ago Oncology drugmakers seek the sweet spot between efficacy and tolerability - about 1 year ago From the rainforest to Wall Street — Jaguar Health’s big play for revitalization - over 1 year ago
10	Alexandra Pecci Pharma Voice Leading community for life sciences leaders. Washington, D.C. pharmaceuticalslife sciencescommunity building	The fortunes and flops of pharma M&A - about 1 year ago

Journalists covering pharmaceutical industry